Alpine Immune Sciences, Inc.
ALPN
|
$64.535
0.16%
0.16%
4M
|
Health Technology
(0.0% 1d) (60.3% 1m) (792.9% 1y) (0.0% 2d) (0.0% 3d) (0.1% 7d) (NaN% volume)
Earnings Calendar: 2024-03-18
Market Cap: $ 4,230,019,887
http://www.alpineimmunesciences.com
Sec Filling | Patents | 53 employees
(US) Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company. The firm engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.
cancer immunotherapy autoimmunity
add to watch list Paper trade email alert is off
Press-releases
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Chord Energy Corp. - CHRD
Published: 2024-04-20 (Crawled : 00:20) - prnewswire.com
ALPN | $64.535 0.16% 0.16% 4M
|
Health Technology
| Email alert
Add to watchlist
WIRE | $284.41 -0.9% -0.91% 620K
|
Producer Manufacturing
| Email alert
Add to watchlist
energy
INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Alpine Immune Sciences, Inc. - ALPN
Published: 2024-04-17 (Crawled : 00:00) - prnewswire.com
WIRE | $284.41 -0.9% -0.91% 620K
|
Producer Manufacturing
|
| O: -1.08%
H: 0.0%
C: 0.0%
ALPN | $64.535 0.16% 0.16% 4M
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: -1.13%
H: 0.28%
C: -0.58%
ALPN | $64.535 0.16% 0.16% 4M
|
Health Technology
|
| O: -2.7%
H: 26.26%
C: 24.15%
nephropathy sciences
Alpine Immune Sciences to Present Updated Clinical Data for Povetacicept in IgA Nephropathy at the World Congress of Nephrology 2024
Published: 2024-04-01 (Crawled : 22:00) - biospace.com/
ALPN | $64.535 0.16% 0.16% 4M
|
Health Technology
|
| O: -0.83%
H: 2.52%
C: 2.31%
nephropathy congress world sciences
Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024
Published: 2024-03-21 (Crawled : 13:00) - biospace.com/
ALPN | $64.535 0.16% 0.16% 4M
|
Health Technology
|
| O: 0.7%
H: 5.85%
C: 2.69%
lupus sciences meeting
Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results
Published: 2024-03-18 (Crawled : 00:00) - biospace.com/
ALPN | $64.535 0.16% 0.16% 4M
|
Health Technology
|
| O: 0.22%
H: 0.92%
C: -2.72%
year update sciences financial results
Alpine Immune Sciences to Report Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-07 (Crawled : 00:00) - biospace.com/
ALPN | $64.535 0.16% 0.16% 4M
|
Health Technology
|
| O: 0.93%
H: 0.93%
C: -4.91%
report year sciences financial results
Alpine Immune Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2023-12-18 (Crawled : 23:00) - biospace.com/
ALPN | $64.535 0.16% 0.16% 4M
|
Health Technology
|
| O: 0.0%
H: 0.69%
C: 0.11%
conference sciences
Key Market Analysis of Sickle Cell Disease, Fanconi Anemia, and Diamond-Blackfan Anemia in the Inherited Types of Anemia Therapeutic Space | Insights by DelveInsight
Published: 2023-11-20 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.13%
H: 1.36%
C: 0.38%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.88%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -2.76%
H: 1.5%
C: 0.06%
ALPN | $64.535 0.16% 0.16% 4M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: -3.79%
anemia cell space market
Alpine Immune Sciences Presents New Translational Data on Povetacicept in Systemic Lupus Erythematosus at American College of Rheumatology Convergence 2023
Published: 2023-11-15 (Crawled : 15:30) - biospace.com/
ALPN | $64.535 0.16% 0.16% 4M
|
Health Technology
|
| O: 6.61%
H: 9.79%
C: -0.94%
lupus sciences
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10